Society guideline links: Diagnosis of hepatitis B

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Management of hepatitis B".)

●(See "Society guideline links: Prevention of hepatitis B virus infection".)

●(See "Society guideline links: Hepatitis B infection in solid organ transplant candidates and recipients".)

●(See "Society guideline links: Travel medicine".)

International

●World Health Organization (WHO): Guidelines for the prevention, diagnosis, care, and treatment for people with chronic hepatitis B infection (2024)

●WHO: Consolidated guidelines on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations (2022)

●WHO: Guidelines on hepatitis B and C testing (2017)

●World Gastroenterology Organisation (WGO): Practice guideline on hepatitis B (2015)

Canada

●Choosing Wisely Canada: Don't routinely do serologic testing post-immunization (ie, hepatitis B and measles) (2023)

●Society of Obstetricians and Gynaecologists of Canada (SOGC): Clinical practice guideline on intrauterine fetal diagnostic testing in women with chronic viral infections (2020)

●SOGC: Clinical practice guideline on hepatitis B and pregnancy (2017)

●Public Health Agency of Canada (PHAC): Primary care management of hepatitis B – Quick reference (HBV-QR) (2014)

United States

●Centers for Disease Control and Prevention (CDC): Hepatitis B – Professional resources

•Recommendations on screening and testing for hepatitis B virus infection, United States (2023)

•Epidemiology and Prevention of Vaccine-Preventable Diseases ("The Pink Book") – Hepatitis B (2021)

•Sexually Transmitted Infections Treatment Guidelines – Hepatitis B virus (HBV) infection (2021)

●American Academy of Pediatrics (AAP): Red Book – Hepatitis B (2024)

●Infectious Diseases Society of America (IDSA) and American Society for Microbiology (ASM): Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases, update (2024)

●US Department of Health and Human Services (HHS): Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Hepatitis B virus infection (2023, reviewed 2024)

●American Society of Clinical Oncology (ASCO): Provisional clinical opinion on hepatitis B virus screening and management for patients with cancer prior to therapy, update (2020)

●US Preventive Services Task Force (USPSTF): Final recommendation statement on hepatitis B virus infection – Screening (2020)

●USPSTF: Final recommendation statement on hepatitis B in pregnant women – Screening (2019)

●American Association for the Study of Liver Diseases (AASLD): Practice guidance on prevention, diagnosis, and treatment of chronic hepatitis B, update (2018)

•AASLD: Guidelines for treatment of chronic hepatitis B (2016)

●American Academy of Family Physicians (AAFP): Clinical preventive service recommendation on hepatitis B virus chronic infection screening (2014)

●American Gastroenterological Association (AGA): Guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy (2014)

●US Department of HHS: Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV – Hepatitis B virus (2013)

Europe

●European Centre for Disease Prevention and Control (ECDC): Public health guidance on HIV, hepatitis B and C testing in the EU/EEA (2018)

●European Association for the Study of the Liver (EASL): Clinical practice guidelines on the management of hepatitis B virus infection (2017)

United Kingdom

●UK Health Security Agency (UKHSA): The Green Book – Immunisation against infectious disease: Hepatitis B (2013, updated 2024)

●National Institute for Health and Care Excellence (NICE): Clinical guideline on hepatitis B (chronic) – Diagnosis and management (2013, updated 2017)

●NICE: Quality standard on hepatitis B (2014)

●NICE: Public health guideline on hepatitis B and C testing – People at risk of infection (2012, updated 2013)

India

●Asian Pacific Association for the Study of the Liver (APASL): Guidelines on hepatitis B virus in pregnancy (2022)

●Ministry of Health and Family Welfare (MOHFW): Technical guidelines for diagnosis and management of hepatitis B (2019)

●Indian National Association for Study of the Liver (INASL): Position statements on prevention, diagnosis, and management of hepatitis B virus infection in India – The Andaman statements (2018)

●APASL: Asian-Pacific clinical practice guidelines on the management of hepatitis B, 2015 update (published 2016)

Australia–New Zealand

●Asian Pacific Association for the Study of the Liver (APASL): Guidelines on hepatitis B virus in pregnancy (2022)

●Gastroenterological Society of Australia (GESA): Australian consensus recommendations for the management of hepatitis B infection (2022)

●APASL: Asian-Pacific clinical practice guidelines on the management of hepatitis B, 2015 update (published 2016)

Japan

●Asian Pacific Association for the Study of the Liver (APASL): Guidelines on hepatitis B virus in pregnancy (2022)

●APASL: Asian-Pacific clinical practice guidelines on the management of hepatitis B, 2015 update (published 2016)